Treatment Information

Back

Mesothelioma treatment details. Biologic therapy.

Netherlands Cancer Institute, Amsterdam, Netherlands.

Survival: monthsCountry:Netherlands
Toxiciy Grade:4City/State/Province:Amsterdam
Treatments:Biologic therapyHospital:Netherlands Cancer Institute
Drugs:Journal:Link
Date:May 2013

Description:

Patients:
This phase 3 study involved 111 malignant pleural mesothelioma patients who had previously received chemotherapy that contained pemetrexed. The median patient age was 64 years and 83% were male.

Treatment:
Patients were treated with the biologic therapy agent thalidomide.

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia and fatigue.

Results:
The median overall survival was 10.6 months.

Support:
This study was partially supported by Eli Lilly.

Correspondence: Dr. Wieneke A Buikhuisen; email: [email protected]



Back